Replies to post #2165 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

You are really missing the point in these results being released.

This data shows that GR-MD-02 works in a human, clinical trial, just read Traber's CEO Perspective on the how these results would be evaluated.

This is the END of the nonsense permeated by Feuerstein and his dbag associates about GR-MD-02 being a 'sugar pill'

This is the BEGINNING of a series of human clinical results that mirror the findings in the animal trials.

GALT's management may have made some PR blunders along the way but, as I have said in the past, they are dead on with their clinical work and I'd rather have that than the other way around.